Cargando…
Cyclic Oligosaccharides as Active Drugs, an Updated Review
There have been many reviews of the cyclic oligosaccharide cyclodextrin (CD) and CD-based materials used for drug delivery, but the capacity of CDs to complex different agents and their own intrinsic properties suggest they might also be considered for use as active drugs, not only as carriers. The...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601923/ https://www.ncbi.nlm.nih.gov/pubmed/33003610 http://dx.doi.org/10.3390/ph13100281 |
_version_ | 1783603548313878528 |
---|---|
author | Matencio, Adrián Caldera, Fabrizio Cecone, Claudio López-Nicolás, José Manuel Trotta, Francesco |
author_facet | Matencio, Adrián Caldera, Fabrizio Cecone, Claudio López-Nicolás, José Manuel Trotta, Francesco |
author_sort | Matencio, Adrián |
collection | PubMed |
description | There have been many reviews of the cyclic oligosaccharide cyclodextrin (CD) and CD-based materials used for drug delivery, but the capacity of CDs to complex different agents and their own intrinsic properties suggest they might also be considered for use as active drugs, not only as carriers. The aim of this review is to summarize the direct use of CDs as drugs, without using its complexing potential with other substances. The direct application of another oligosaccharide called cyclic nigerosyl-1,6-nigerose (CNN) is also described. The review is divided into lipid-related diseases, aggregation diseases, antiviral and antiparasitic activities, anti-anesthetic agent, function in diet, removal of organic toxins, CDs and collagen, cell differentiation, and finally, their use in contact lenses in which no drug other than CDs are involved. In the case of CNN, its application as a dietary supplement and immunological modulator is explained. Finally, a critical structure–activity explanation is provided. |
format | Online Article Text |
id | pubmed-7601923 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76019232020-11-01 Cyclic Oligosaccharides as Active Drugs, an Updated Review Matencio, Adrián Caldera, Fabrizio Cecone, Claudio López-Nicolás, José Manuel Trotta, Francesco Pharmaceuticals (Basel) Review There have been many reviews of the cyclic oligosaccharide cyclodextrin (CD) and CD-based materials used for drug delivery, but the capacity of CDs to complex different agents and their own intrinsic properties suggest they might also be considered for use as active drugs, not only as carriers. The aim of this review is to summarize the direct use of CDs as drugs, without using its complexing potential with other substances. The direct application of another oligosaccharide called cyclic nigerosyl-1,6-nigerose (CNN) is also described. The review is divided into lipid-related diseases, aggregation diseases, antiviral and antiparasitic activities, anti-anesthetic agent, function in diet, removal of organic toxins, CDs and collagen, cell differentiation, and finally, their use in contact lenses in which no drug other than CDs are involved. In the case of CNN, its application as a dietary supplement and immunological modulator is explained. Finally, a critical structure–activity explanation is provided. MDPI 2020-09-29 /pmc/articles/PMC7601923/ /pubmed/33003610 http://dx.doi.org/10.3390/ph13100281 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Matencio, Adrián Caldera, Fabrizio Cecone, Claudio López-Nicolás, José Manuel Trotta, Francesco Cyclic Oligosaccharides as Active Drugs, an Updated Review |
title | Cyclic Oligosaccharides as Active Drugs, an Updated Review |
title_full | Cyclic Oligosaccharides as Active Drugs, an Updated Review |
title_fullStr | Cyclic Oligosaccharides as Active Drugs, an Updated Review |
title_full_unstemmed | Cyclic Oligosaccharides as Active Drugs, an Updated Review |
title_short | Cyclic Oligosaccharides as Active Drugs, an Updated Review |
title_sort | cyclic oligosaccharides as active drugs, an updated review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601923/ https://www.ncbi.nlm.nih.gov/pubmed/33003610 http://dx.doi.org/10.3390/ph13100281 |
work_keys_str_mv | AT matencioadrian cyclicoligosaccharidesasactivedrugsanupdatedreview AT calderafabrizio cyclicoligosaccharidesasactivedrugsanupdatedreview AT ceconeclaudio cyclicoligosaccharidesasactivedrugsanupdatedreview AT lopeznicolasjosemanuel cyclicoligosaccharidesasactivedrugsanupdatedreview AT trottafrancesco cyclicoligosaccharidesasactivedrugsanupdatedreview |